Madrigal Pharmaceuticals Inc (MDGL)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$434.00
Buy
$447.13
$-2.65 (-0.59%)
Prices updated at 20 Oct 2026, 00:30 EDT
| Prices minimum 15 mins delay
Prices in USD
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver fa ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $454.50 - $443.48 | |
| $615.00 - $393.61 | |
| - | |
| 10,386.00m | |
| - | |
| - | |
| 263,793 | |
| 19.83 | |
| 335,751.05 | |
| 1.30 | |
| 22.84m | |
| US5588681057 | |
| -12.85 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.